FREE CONSULTATION - CALL NOW!

212-LAWYERS or (212) 344-1000

Misdiagnosis of Lung Cancer Due to Negligence is Medical Malpractice

Lung cancer is a silent disease and exhibits almost no symptoms during its early stages. Delay in diagnosing lung cancer is a frequent incident, as it can be confused with symptoms of other less complicated and critical conditions such as bronchitis, pneumonia, asthma, and chronic obstructive pulmonary disease.

The symptoms of hemorrhoids and colon cancer

Colon cancer is a leading cause of death across the country. Like a majority of cancers, it does not show any real signs of being there until it advances, making it hard to diagnose early and increasing the odds of misdiagnosis. New York patients could stay informed about the disease to help avoid being misdiagnosed with other conditions such as hemorrhoids.

Bladder Cancer Symptoms can be Mistaken for those of a Minor Infection

The bladder is a balloon-shaped organ in the pelvic region that stores urine. Bladder cancer can have some obvious signs and symptoms which help its diagnosis at an early stage, and is a condition that is fully treatable. This however does not rule out the possibility of recurrence of the cancer, even if it was diagnosed and treated at an early stage.

Failure to Diagnose or Appropriately Treat Liver Cancer Constitutes Medical Malpractice

As the name suggests, liver cancer originates in the liver and is one of the most dangerous and fast-spreading cancers known. The majority affected is the elderly population, and a delay in diagnosis or misdiagnosis could prove fatal. Cancer that starts in the liver is called primary liver cancer, while cancers that start in other organs and spread to the liver are called secondary liver cancer.

Earlier breast cancer detection leads to better outcome

New York women may be interested in the results of a new study that demonstrates the importance of early breast cancer detection. Researchers from the Netherlands Comprehensive Cancer Organization, the University of Twente and Erasmus University Medical Center looked at medical data that was collected from approximately 174,000 Dutch women who had been diagnosed with breast cancer between 1999 and 2012.